The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stüve, O.
Right arrow Articles by Zamvil, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stüve, O.
Right arrow Articles by Zamvil, S. S.
The Journal of Immunology, 2002, 169: 6720-6732.
Copyright © 2002 by The American Association of Immunologists

The Role of the MHC Class II Transactivator in Class II Expression and Antigen Presentation by Astrocytes and in Susceptibility to Central Nervous System Autoimmune Disease1

Olaf Stüve*, Sawsan Youssef{ddagger}, Anthony J. Slavin§, Chelsea L. King*, Juan Carlos Patarroyo*, David L. Hirschberg{ddagger}, W. June Brickey, Jeanne M. Soos||, Janet F. Piskurich#, Harold A. Chapman{dagger} and Scott S. Zamvil2,*

Departments of * Neurology and {dagger} Pulmonary Medicine, University of California, San Francisco, CA 94143; {ddagger} Department of Neurology, Stanford University, Stanford, CA 94305; § Tularik, South San Francisco, CA 94080; University of North Carolina, Chapel Hill, NC 27599; and || Glaxo SmithKline Pharmaceuticals, King of Prussia, PA 19406; and # Mercer University School of Medicine, Macon, GA 31207

The role of the MHC class II transactivator (CIITA) in Ag presentation by astrocytes and susceptibility to experimental autoimmune encephalomyelitis (EAE) was examined using CIITA-deficient mice and newly created transgenic mice that used the glial fibrillary acidic protein promoter to target CIITA expression in astrocytes. CIITA was required for class II expression on astrocytes. Like class II-deficient mice, CIITA-deficient mice were resistant to EAE by immunization with CNS autoantigen, although T cells from immunized CIITA-deficient, but not class II-deficient, mice proliferated and secreted Th1 cytokines. CIITA-deficient splenic APC presented encephalitogenic peptide to purified wild-type encephalitogenic CD4+ T cells, indicating that CIITA-independent mechanisms can be used for class II-restricted Ag presentation in lymphoid tissue. CIITA-deficient mice were also resistant to EAE by adoptive transfer of encephalitogenic class II-restricted CD4+ Th1 cells, indicating that CIITA-dependent class II expression was required for CNS Ag presentation. Despite constitutive CIITA-driven class II expression on astrocytes in vivo, glial fibrillary acidic protein-CIITA transgenic mice were no more susceptible to EAE than controls. CIITA-transfected astrocytes presented peptide Ag, but in contrast to IFN-{gamma}-activated astrocytes, they could not process and present native Ag. CIITA-transfected astrocytes did not express cathepsin S without IFN-{gamma} activation, indicating that CIITA does not regulate other elements that may be required for Ag processing by astrocytes. Although our results demonstrate that CIITA-directed class II expression is required for EAE induction, CIITA-directed class II expression by astrocytes does not appear to increase EAE susceptibility. These results do not support the role of astrocytes as APC for class II-restricted Ag presentation during the induction phase of EAE.




This article has been cited by other articles:


Home page
BrainHome page
W. Hu, S. Nessler, B. Hemmer, T. N. Eagar, L. P. Kane, S. R. Leliveld, A. Muller-Schiffmann, A. R. Gocke, A. Lovett-Racke, L.-H. Ben, et al.
Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling
Brain, February 9, 2010; (2010) awp298v1.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Harnesk, M. Swanberg, J. Ockinger, M. Diez, O. Lidman, E. Wallstrom, A. Lobell, T. Olsson, and F. Piehl
Vra4 Congenic Rats with Allelic Differences in the Class II Transactivator Gene Display Altered Susceptibility to Experimental Autoimmune Encephalomyelitis
J. Immunol., March 1, 2008; 180(5): 3289 - 3296.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Soualhine, A.-E. Deghmane, J. Sun, K. Mak, A. Talal, Y. Av-Gay, and Z. Hmama
Mycobacterium bovis Bacillus Calmette-Guerin Secreting Active Cathepsin S Stimulates Expression of Mature MHC Class II Molecules and Antigen Presentation in Human Macrophages
J. Immunol., October 15, 2007; 179(8): 5137 - 5145.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Zhu, Y. Bando, S. Xiao, K. Yang, A. C. Anderson, V. K. Kuchroo, and S. J. Khoury
CD11b+Ly-6Chi Suppressive Monocytes in Experimental Autoimmune Encephalomyelitis
J. Immunol., October 15, 2007; 179(8): 5228 - 5237.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
A. Martinez, M. Sanchez-Lopez, J. Varade, A. Mas, M Carmen Martin, V. de las Heras, R. Arroyo, J. Luis Mendoza, M. Diaz-Rubio, B. Fernandez-Gutierrez, et al.
Role of the MHC2TA gene in autoimmune diseases
Ann Rheum Dis, March 1, 2007; 66(3): 325 - 329.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Kimura, M. Kimura, S.-C. Tzou, Y.-C. Chen, K. Suzuki, N. R. Rose, and P. Caturegli
Expression of Class II Major Histocompatibility Complex Molecules on Thyrocytes Does Not Cause Spontaneous Thyroiditis but Mildly Increases Its Severity after Immunization
Endocrinology, March 1, 2005; 146(3): 1154 - 1162.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.